In this study, on the one hand, we were interested in analyzing the number of CTCs and their AR-V7 expression and, on the other hand, we were interested in quantifying cfDNA and characterizing its genomic alterations in the same metastatic PCa patients. The gene discussed is AR; the disease is posterior cortical atrophy.